Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir

International Journal of Antimicrobial Agents

Volumn 24, Issue 3, 2004, Pages 284-285

  Cicconi, P ^a   Bongiovanni, M ^a   Melzi, S ^a   Tordato, F ^a   D'Arminio Monforte, A ^a   Bini, T ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

HIV; Nephrolithiasis; Tenofovir

Indexed keywords

TENOFOVIR; TENOFOVIR DISOPROXIL; ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DRUG DERIVATIVE; PHOSPHONIC ACID DERIVATIVE;

ADULT; ANAMNESIS; ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRONEPHROSIS; MALE; NEPHROLITHIASIS; NEPHROTOXICITY; PATIENT MONITORING; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER;

ADENINE; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; HYDRONEPHROSIS; KIDNEY CALCULI; MALE; PHOSPHONIC ACIDS;

EID: 4344615378     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.04.005     Document Type: Article

References (8)

1. Schooley R.T., Ruane P., Myers R.A., et al. Tenofovir DF in antiretroviral experienced patients: results from a 48-week randomised double blind study. AIDS. 16:2002;1257-1263
2. Wainberg M.A., Miller M.D., Quan Y., et al. In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA. Antivir. Ther. 4:1999;87-94
3. Shirasaka T., Kavlick M.F., Ueno T., Gao W.Y., Kojima E., Alcaide M.L. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. U.S.A. 92:1995;2398-2402
4. Viread (tenofovir disoproxil fumarate) package insert. Foster City, CA: Gilead Sciences; 2001.
5. Cihlar T., Ho E., Lin D., Mulato A.S. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids. 20:2001;641-648
6. Dobkin J.F. Tenofovir: the first nucleotide for HIV infection. Infect. Med. 19:2002;11
7. Creput C., Gonzalez-Canali G., Hill G., Piketty C., Kazatchkine M., Nochy D. Renal lesions in HIV-1 positive patient treated with tenofovir. AIDS. 17:2003;935-937
8. Murphy M.D., O'Hearn M., Chou S. Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine. Clin. Infect. Dis. 36:2003;1082-1085